These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
199 related articles for article (PubMed ID: 24856644)
1. Effects of peroxisome proliferator-activated receptor γ in simvastatin antiplatelet activity: influences on cAMP and mitogen-activated protein kinases. Du H; Hu H; Zheng H; Hao J; Yang J; Cui W Thromb Res; 2014 Jul; 134(1):111-20. PubMed ID: 24856644 [TBL] [Abstract][Full Text] [Related]
2. Inhibitory effect of α-lipoic acid on platelet aggregation is mediated by PPARs. Chou TC; Shih CY; Chen YT J Agric Food Chem; 2011 Apr; 59(7):3050-9. PubMed ID: 21391669 [TBL] [Abstract][Full Text] [Related]
3. Mechanisms of antiplatelet activity of nifedipine: role of peroxisome proliferator-activated receptor-β-γ-dependent processes. Shih CY; Lin MH; Fan HC; Chen FC; Chou TC J Hypertens; 2014 Jan; 32(1):181-92. PubMed ID: 24126710 [TBL] [Abstract][Full Text] [Related]
4. Cyclic nucleotides and mitogen-activated protein kinases: regulation of simvastatin in platelet activation. Lee YM; Chen WF; Chou DS; Jayakumar T; Hou SY; Lee JJ; Hsiao G; Sheu JR J Biomed Sci; 2010 Jun; 17(1):45. PubMed ID: 20525309 [TBL] [Abstract][Full Text] [Related]
5. Potent antiplatelet activity of sesamol in an in vitro and in vivo model: pivotal roles of cyclic AMP and p38 mitogen-activated protein kinase. Chang CC; Lu WJ; Chiang CW; Jayakumar T; Ong ET; Hsiao G; Fong TH; Chou DS; Sheu JR J Nutr Biochem; 2010 Dec; 21(12):1214-21. PubMed ID: 20015631 [TBL] [Abstract][Full Text] [Related]
6. The antiplatelet activity of magnolol is mediated by PPAR-β/γ. Shih CY; Chou TC Biochem Pharmacol; 2012 Sep; 84(6):793-803. PubMed ID: 22750553 [TBL] [Abstract][Full Text] [Related]
7. Antiplatelet activity of Phellinus baummii methanol extract is mediated by cyclic AMP elevation and inhibition of collagen-activated integrin-α(IIb) β₃ and MAP kinase. Kamruzzaman SM; Endale M; Oh WJ; Park SC; Kim TH; Lee IK; Cho JY; Park HJ; Kim SK; Yun BS; Rhee MH Phytother Res; 2011 Nov; 25(11):1596-603. PubMed ID: 21394810 [TBL] [Abstract][Full Text] [Related]
8. Antiplatelet effects of caffeic acid due to Ca(2+) mobilizationinhibition via cAMP-dependent inositol-1, 4, 5-trisphosphate receptor phosphorylation. Lee DH; Kim HH; Cho HJ; Bae JS; Yu YB; Park HJ J Atheroscler Thromb; 2014; 21(1):23-37. PubMed ID: 24088646 [TBL] [Abstract][Full Text] [Related]
9. Reduction of platelet cytosolic phospholipase A2 activity by atorvastatin and simvastatin: biochemical regulatory mechanisms. Moscardó A; Vallés J; Latorre A; Madrid I; Santos MT Thromb Res; 2013 Apr; 131(4):e154-9. PubMed ID: 23352311 [TBL] [Abstract][Full Text] [Related]
10. A noble function of BAY 11-7082: Inhibition of platelet aggregation mediated by an elevated cAMP-induced VASP, and decreased ERK2/JNK1 phosphorylations. Lee HS; Kim SD; Lee WM; Endale M; Kamruzzaman SM; Oh WJ; Cho JY; Kim SK; Cho HJ; Park HJ; Rhee MH Eur J Pharmacol; 2010 Feb; 627(1-3):85-91. PubMed ID: 19913011 [TBL] [Abstract][Full Text] [Related]
11. Inhibitory effect of caffeic acid on ADP-induced thrombus formation and platelet activation involves mitogen-activated protein kinases. Lu Y; Li Q; Liu YY; Sun K; Fan JY; Wang CS; Han JY Sci Rep; 2015 Sep; 5():13824. PubMed ID: 26345207 [TBL] [Abstract][Full Text] [Related]
12. Ginsenoside-Rp3 inhibits platelet activation and thrombus formation by regulating MAPK and cyclic nucleotide signaling. Irfan M; Jeong D; Kwon HW; Shin JH; Park SJ; Kwak D; Kim TH; Lee DH; Park HJ; Rhee MH Vascul Pharmacol; 2018 Oct; 109():45-55. PubMed ID: 29890296 [TBL] [Abstract][Full Text] [Related]
13. Inhibitory signaling of 17β-estradiol in platelet activation: the pivotal role of cyclic AMP-mediated nitric oxide synthase activation. Wu GJ; Lee JJ; Chou DS; Jayakumar T; Hsiao G; Chen WF; Sheu JR Eur J Pharmacol; 2010 Dec; 649(1-3):140-9. PubMed ID: 20883689 [TBL] [Abstract][Full Text] [Related]
14. p-Terphenyl curtisian E inhibits in vitro platelet aggregation via cAMP elevation and VASP phosphorylation. Kamruzzaman SM; Yayeh T; Ji HD; Park JY; Kwon YS; Lee IK; Kim S; Oh SH; Kim SD; Roh SS; Yun BS; Rhee MH Vascul Pharmacol; 2013; 59(3-4):83-9. PubMed ID: 23872194 [TBL] [Abstract][Full Text] [Related]
15. Antiplatelet actions of statins and fibrates are mediated by PPARs. Ali FY; Armstrong PC; Dhanji AR; Tucker AT; Paul-Clark MJ; Mitchell JA; Warner TD Arterioscler Thromb Vasc Biol; 2009 May; 29(5):706-11. PubMed ID: 19150877 [TBL] [Abstract][Full Text] [Related]
16. Ex vivo and in vivo studies of CME-1, a novel polysaccharide purified from the mycelia of Cordyceps sinensis that inhibits human platelet activation by activating adenylate cyclase/cyclic AMP. Lu WJ; Chang NC; Jayakumar T; Liao JC; Lin MJ; Wang SH; Chou DS; Thomas PA; Sheu JR Thromb Res; 2014 Dec; 134(6):1301-10. PubMed ID: 25294588 [TBL] [Abstract][Full Text] [Related]
17. Inhibitory mechanisms of resveratrol in platelet activation: pivotal roles of p38 MAPK and NO/cyclic GMP. Shen MY; Hsiao G; Liu CL; Fong TH; Lin KH; Chou DS; Sheu JR Br J Haematol; 2007 Nov; 139(3):475-85. PubMed ID: 17868048 [TBL] [Abstract][Full Text] [Related]
18. A novel antithrombotic effect of sulforaphane via activation of platelet adenylate cyclase: ex vivo and in vivo studies. Jayakumar T; Chen WF; Lu WJ; Chou DS; Hsiao G; Hsu CY; Sheu JR; Hsieh CY J Nutr Biochem; 2013 Jun; 24(6):1086-95. PubMed ID: 23246160 [TBL] [Abstract][Full Text] [Related]
19. Arsenic trioxide-mediated antiplatelet activity: pivotal role of the phospholipase C gamma 2-protein kinase C-p38 MAPK cascade. Lin KH; Chang YF; Fan CY; Jayakumar T; Lee JJ; Chou DS; Hsiao G; Sheu JR Transl Res; 2010 Feb; 155(2):97-108. PubMed ID: 20129490 [TBL] [Abstract][Full Text] [Related]
20. Antiplatelet Activity of a Newly Synthesized Novel Ruthenium (II): A Potential Role for Akt/JNK Signaling. Khamrang T; Hung KC; Hsia CH; Hsieh CY; Velusamy M; Jayakumar T; Sheu JR Int J Mol Sci; 2017 Apr; 18(5):. PubMed ID: 28448438 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]